That is the question Luis Garicano asks in his recent post. He relies on projections from the 2025 IMF World Economic Outlook. On the positive side, Eastern European countries’ economies are likely to converge with the US. While we have spent a decade complaining about Europe’s stagnation, a real positive convergence story has been unfolding…
By KIM BELLARD A New York Times interview with Rep. Jake Auchincloss (D – Mass) by Bret Stephens caught my attention. I am somewhat familiar with Mr. Stephens from his various pieces in NYT; he is definitely a conservative, but in the old, pre-MAGA sense where it meant you worried about spending but you didn’t…
This is one of those “Coming Soon” announcements. I spent the weekend with the wonderful gang from what I affectionately call Camp Claudia Cult, a group of mostly Californian policy wonks led by Claudia Williams, who these days is at the UC Berkeley School of public health. As you may have noticed I’ve been spending…
Healthcare leaders are divided over the Trump administration’s proposed rule to expand employer-sponsored fertility benefits, with some praising broader access and others saying it falls short of guaranteeing comprehensive coverage. The post How Healthcare Leaders are Reacting to the White House’s Proposed Fertility Benefit Rule appeared first on MedCity News.
The initiative seeks to boost confidence among women and healthcare providers in AI tools
This year, we are hosting a new event called Bullseye: Targeting Healthier Outcomes & Returns on July 23 in Chicago. It’s invitation-only and exclusively for healthcare investors and corporate business development leads. Join the waitlist for a chance to be in the room with your peers. The post Inviting Investors and Corporate Business Development Leaders…
Sanford Health signed a deal to acquire North Memorial Health, which could be its long-sought entry into the Twin Cities market. The move is the latest in a series of expansion efforts for the South Dakota-based health system. The post Sanford Health Continues M&A Push with North Memorial Health Deal appeared first on MedCity News.
Bristol Myers Squibb is paying $600 million up front to begin a 13-drug collaboration with Hengrui Pharma spanning oncology, hematology, and immunology. That tops a 12-drug pact GSK inked last year with Hengrui, a China-based company that has global growth ambitions. The post Bristol Myers, Hengrui Pharma Team Up in Global Drug Research Pact That…
Speaking at WEDI spring conference, new HL7 leader talks about alignment with CMS goals
Also: Nutex wants to speed up hospital development and a PE firm is buying Cross Country Healthcare.